Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cellular Proliferation Imaging Using [18F] Fluorothymidine (FLT) Positron Emission Tomography (PET) in Brain Tumors

NCT02167204 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT02167204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02167204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cellular Proliferation Imaging Using [18F] Fluorothymidine (FLT) Positron Emission Tomography (PET) in Brain Tumors
Lead sponsor
University of Washington
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2012
Completion date
January 21, 2019
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant neoplasm in the brain, primary brain neoplasm, recurrent brain neoplasm